New heart valve device shows promise in early study

NCT ID NCT07116551

Ongoing Disease control Sponsor: Abbott Medical Devices Source: ClinicalTrials.gov ↗

First seen Nov 06, 2025 · Last updated May 15, 2026 · Updated 26 times

Summary

This study tests a new balloon-expandable heart valve system from Abbott for people with severe aortic stenosis, a condition where the heart's main valve is narrowed. The goal is to see if the device is safe and works as intended. Eleven adults with severe symptoms are taking part in this early feasibility trial.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYMPTOMATIC SEVERE AORTIC STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Abbott Northwestern Hospital

Minneapolis, Minnesota, 55407, United States
Clinique Pasteur Toulouse

Toulouse, Midpyre, 31076, France
Columbia University Medical Center/New York-Presbyterian

New York, New York, 10032, United States
Montefiore Medical Center - Moses Division

The Bronx, New York, 10461, United States
Via Christi Regional Medical Center

Wichita, Kansas, 67214, United States

Conditions

Explore the condition pages connected to this study.

SYMPTOMATIC SEVERE AORTIC STENOSIS